/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Marie José Kersten

Dutch Cancer Society(NL)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

573

Papers

19.1K

Citations

65

h-index

240

i10-index

Marie José Kersten is an academic researcher from Dutch Cancer Society. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & CAR-T cell therapy research & Chronic Lymphocytic Leukemia Research. The author has an h-index of 65, co-authored 488 publications.

ORCID: 0000-0002-8904-3802

Research Topics

Lymphoma Diagnosis and Treatment CAR-T cell therapy research Chronic Lymphocytic Leukemia Research Multiple Myeloma Research and Treatments Viral-associated cancers and disorders

Papers by this author

works

Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

2012 · Journal of Clinical Oncology · 821 citations

https://doi.org/10.1200/jco.2011.39.6820

Pieter Sonneveld Ingo Schmidt‐Wolf Bronno van der Holt Laila el Jarari

Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs

2016 · Cancer Treatment Reviews · 595 citations

https://doi.org/10.1016/j.ctrv.2016.11.010

Laurien M. Buffart Joeri Kalter Maike G. Sweegers Kerry S. Courneya

Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations

2023 · Blood · 266 citations

https://doi.org/10.1182/blood.2023020578

Kai Rejeski Marion Subklewe Mahmoud Aljurf Emmanuel Bachy

Prognostic Significance of <i>MYC</i> Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium

2019 · Journal of Clinical Oncology · 247 citations

https://doi.org/10.1200/jco.19.00743

Andreas Rosenwald Susanne Bens Ranjana H. Advani Sharon Barrans

High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites

2013 · Blood Cancer Journal · 201 citations

https://doi.org/10.1038/bcj.2013.28

Willem Kraan Hugo M. Horlings Martine van Keimpema Esther J.M. Schilder-Tol

Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

2021 · Leukemia · 113 citations

https://doi.org/10.1038/s41375-021-01466-0

Anne M. Spanjaart Per Ljungman Rafael de la Cámara Gloria Tridello

Research topics

topics

Lymphoma Diagnosis and Treatment

CAR-T cell therapy research

Chronic Lymphocytic Leukemia Research

Multiple Myeloma Research and Treatments

Viral-associated cancers and disorders

Chat about Author

Papers

Chat

Click to start Chat